1)Strandberg TE, et al : NNT is highly misleading when assessing chronic disease prevention. BMJ 394 : g4167, 2014
2)厚生労働省健康局結核感染症課(編) : 抗微生物薬適正使用の手引き,第二版,ダイジェスト版.pp1-4,厚生労働省健康局結核感染症課,2019
3)Arthur LE, et al : Antibiotics for ventilator-associated pneumonia. Cochrane Database Syst Rev 10 : CD004267, 2016
4)Muhammad M, et al : Comparison between carbapenems and β-lactam/β-lactamase inhibitors in the treatment for bloodstream infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae : a systematic review and meta-analysis. Open Forum Infect Dis 16 : ofx099, 2017
5)McLaughlin M, et al : Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae. Antimicrob Agents Chemother 57 : 5131-5133, 2013
6)Voor In 't Holt AF, et al : A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 58 : 2626-2637, 2014
7)Lodise TP Jr, et al : Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 51 : 3731-3733, 2007
8)Kim SH, et al : Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 52 : 192-197, 2008
9)Yamada K, et al : The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria. J Infect Chemother 25 : 1001-1006, 2019
10)Lee A, et al : Detection of bloodstream infections in adults : how many blood cultures are needed? J Clin Microbiol 45 : 3546-3548, 2007